The in vitro effects of chylomicron remnant and very low density lipoprotein remnant on platelet aggregation in blood obtained from healthy persons

Thrombosis Research

Volumn 81, Issue 5, 1996, Pages 583-593

  Mochizuki, Masae ^a   Takada, Yumiko ^a   Urano, Tetsumei ^a   Nagai, Nobuo ^a   Nakano, Takamitsu ^b   Nakajima, Katsuyuki ^b   Takada, Akikazu ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b JAPAN IMMUNORESEARCH LABORATORIES   (Japan)

Author keywords

chylomicron; platelet aggregation; remnant lipoprotein; VLDL

Indexed keywords

CHYLOMICRON; LIPOPROTEIN; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION;

EID: 0029881643     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-3848(96)00033-3     Document Type: Article

References (37)

1. ZILVERSMIT, D.B. Atherogenesis: a postprandial phenomenon. Circulation 60, 473-485, 1979.
2. AVIRAM, M. and BROOK, J.G. Platelet interaction with high and low density lipoproteins. Atherosclerosis 46, 259-268, 1983.
3. AVIRAM, M. and BROOK, J. G. Platelet activation by plasma lipoproteins. [Review]. Prog Cardiovasc Dis 30, 61-72, 1987.
4. AVIRAM, M. FURMAN, B. and BROOK, J. G. Chylomicrons from patients with type V hyperlipoproteinemia inhibit platelet function. Atherosclerosis 56, 157-167, 1985.
5. BROOK, J.G. and AVIRAM, M. Platelet lipoprotein interactions. [Review]. Semin Thromb Hemost 14, 258-265, 1988.
6. JOIST, J.H. and BAKER, R.K. Increased in vivo and in vitro platelet function in type II and type IV hyperlipoproteinaemia. Thromb Res 15, 95-108, 1974.
7. XU, N. OHLIN, A.K. and NILSSON, A. Chylomicron-induced prothrombin activation and platelet aggregation. Arterioscler Thromb 14, 1014-1020, 1994.
8. NAKAJIMA, K., SAITO, T., TAMURA, A., SUZUKI, M., NAKANO, T. and ADACHI, M. A new approach for the detection of type III hyperlipoproteinemia by RLP-cholesterol assay. J Atheroscler Thromb 1, 30-36, 1994.
9. NAKAJIMA, K., SAITO, T., TAMURA, A., SUZUKI, M., NAKANO, T., ADACHI, M., TANAKA, A., TADA, N., ISHIKAWA, T. and NAKAMURA, H. A new assay method for remnant lipoprotein and its clinical significance. J Jpn Atheroscler Soc 20, 79-88, 1992.
10. TADA, N., NAKAJIMA, K. and NAKAMURA, H. Remnant hyperlipoproteinemia. Prog Med 11, 66-72, 1991.
11. TAKAGI, S., FUKUO, Y., SETA, K., SAITO, T., NAKAJIMA, K., HASEGAWA, T., NAKAJIMA, S. and TERASHI, A. Particle remnants (RLP, Lipo Z) and lipoproteins in patients with chronic cerebral infarction. J Jpn Atheroscler Soc 20, 675-679, 1992.
12. IKEWAKI, K. Postprandial lipemia in patients with coronary artery disease. J Jpn Atheroscler Soc 18, 887-895, 1990.
13. SHIMIZU, H., MORI, M. and SAITO, T. An increase of serum remnant-like particles in non-insulin-dependent diabetic patients with microalbuminuria. Clin Chim Acta 221, 191-196, 1993.
14. NESTEL, P.J., FIDGE, N.H. and TAN, M.H. Increased lipoprotein-remnant formation in chronic renal failure. New Engl J Med307, 329-333, 1982.
15. PHILLIPS, N.R., WATERS, D. and HAVEL, R.J. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 88, 2762-2770, 1993.
16. GINSBERG, H.N. Lipoprotein metabolism and its relationship to atherosclerosis. [Review]. Med Clin N Am78, 1-20, 1994.
17. HARKER, L.A, and HAZZARD, W. Platelet kinetic studies in patients with hyperlipoproteinemia: effects of clofibrate therapy. Circulation 60, 492-496, 1979.
18. KANE, J.P., CHEN, G.C., HAMILTON, R.L., HARDMAN, D.A., MALLOY, M.J. and HAVEL, R.J. Remnants of lipoproteins of intestinal and hepatic origin in familial dysbetalipoproteinemia. Arteriosclerosis 3, 47-56, 1983.
19. MORGANROTH, J., LEVY, R.I. and FREDRICKSON, D.S. The biochemical, clinical, and genetic features of type III hyperlipoproteinemia. Ann Intern Med82, 158-174, 1975.
20. KNOFLER, R., NAKANO, T., NAKAJIMA, K., TAKADA, Y. and TAKADA, A. Remnant-like lipoproteins stimulate whole blood platelet aggregation in vitro. Thromb Res 78, 161-171, 1995.
21. ORTH, M., LULEY, C. and WIELAND, H. Effect of VLDL, chylomicrons, and chylomicron remnant on platelet aggregation. Thromb Res 79, 297-305, 1995.
22. NAKAJIMA, K., SAITO, T., TAMURA, A., SUZUKI, M., NAKANO, T., ADACHI, M., TANAKA, A., TADA, N., NAKAMURA, H. and CAMPOS, E. Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels. Clin Chim Acta 223, 53-71, 1993.
23. ABBATE, R., FAVILLA, S., BODDI, M., COSTANZO, G. and PRISCO, D. Factors influencing platelet aggregation in whole blood. Am J Clin Pathol 86, 91-96, 1986.
24. OKAMOTO, S., HIJIKATA, A., KIKUMOTO, R., TONOMURA, S., HARA, H., NINOMIYA, K., MARUYAMA, A., SUGANO, M. and TAMAO, Y. Potent inhibition of thrombin by the newly synthesized arginine derivative No. 805. The importance of stereo-structure of its hydrophobic carboxamide portion. Biochemical & Biophysical Research Communications 101, 440-6, 1981.
25. HAVEL, R.J., KANE, J.P. and KASHYAP, M.L. Interchange of apolipoproteins between chylomicrons and high density lipoproteins during alimentary lipemia in man. J Clin Invest 52, 32-38, 1973.
26. HASSALL, D.G., FORREST, L.A., BRUCKDORFER, K.R., MARENAH, C.B., TURNER, P., CORTESE, C., MILLER, N.E. and LEWIS, B. Influence of plasma lipoproteins on platelet aggregation in a normal male population. Arteriosclerosis 3, 332-338, 1983.
27. ANDREWS, H.E., AITKEN, J.W., HASSALL, D.G., SKINNER, V.O. and BRUCKDORFER, K.R. Intracellular mechanisms in the activation of human platelets by low-density lipoproteins. Biochem J 242, 559-564, 1987.
28. VAN, W.G., GORTER, G. and AKKERMAN, J.W. LDLs increase the exposure of fibrinogen binding sites on platelets and secretion of dense granules. Arterioscler Thromb 14, 41-46, 1994.
29. FOGER, B. and PATSCH, J.R. Strategies and methods for the assesment of disturbed postprandial lipid metabolism. Curr Opin Lipidol 4, 428-433, 1993.
30. KOZIMA, Y., URANO, T., SERIZAWA, K., TAKADA, Y. and TAKADA, A. Impaired fibrinolytic activity induced by ingestion of butter: effect of increased plasma lipids on the fibrinolytic activity. Thromb Res 70, 191-202, 1993.
31. JOHNSTON, R.V., GINER, J.V., FORBES, C.D. and PRENTICE, C.R.M. The effect of a fat meal on platelet function in man. Thromb Haemostas 42, 435, 1979.
32. NORDOY, A., LAGARDE, M. and RENAUD, S. Platelets during alimentary hyperlipaemia induced by cream and cod liver oil. Eur J Clin Invest 14, 339-345, 1984.
33. BELCH, J.J., SANIABADI, A.R., MCLAUGHLIN, K. and FORBES, C.D. Platelet changes after a saturated fat meal and their prevention by Dazmegrel, a thromboxane synthetase inhibitor. Lipids 22, 159-162, 1987.
34. JAKUBOWSKI, J.A., ARDLIE, N.G., CHESTERMAN, C.N., MCGREADY, J.F. and MORGAN, F.J. Acute postprandial lipaemia does not influence the in vivo activity of human platelets. Thromb Res 39, 725-732, 1985.
35. KNOFLER, R., URANO, T., TAMINATO, T., YOSHIMI, T., NAKANO, T., NAKAJIMA, K., TAKADA, Y. and TAKADA, A. Daily variation of lipids in relation to the circadian rhythm of platelet aggregation in healthy male persons. Clin Chim Acta 239, 109-119, 1995.
36. NAKAJIMA, K., SAITO, T., ADACHI, M., TANAKA, A., MAEZAWA, H., IKEWAKI, K., NAKAMURA, H., CAMPOS, E. and HAVEL, R. A new assay method for the detection of abnormal lipoproteins(remnant lipoproteins) in human plasma using monoclonal antibody anti apo B-100 and anti apo A-1 immunoaffinity gels. Proc. X Int. Symp. 110, 1989.
37. CAMPOS, E., NAKAJIMA, K., TANAKA, A. and HAVEL, R. J. Properties of an apolipoprotein E-enriched fraction of triglyceride-rich lipoproteins isolated from human blood plasma with a monoclonal antibody to apolipoprotein B-100. J Lipid Res 33, 369-80, 1992.